Literature DB >> 26922727

Bioproduction of D-Tagatose from D-Galactose Using Phosphoglucose Isomerase from Pseudomonas aeruginosa PAO1.

Manisha J Patel1, Arti T Patel1, Rekha Akhani1, Samir Dedania1, Darshan H Patel2.   

Abstract

Pseudomonas aeruginosa PAO1 phosphoglucose isomerase was purified as an active soluble form by a single-step purification using Ni-NTA chromatography that showed homogeneity on SDS-PAGE with molecular mass ∼62 kDa. The optimum temperature and pH for the maximum isomerization activity with D-galactose were 60 °C and 7.0, respectively. Generally, sugar phosphate isomerases show metal-independent activity but PA-PGI exhibited metal-dependent isomerization activity with aldosugars and optimally catalyzed the D-galactose isomerization in the presence of 1.0 mM MnCl2. The apparent Km and Vmax for D-galactose under standardized conditions were calculated to be 1029 mM (±31.30 with S.E.) and 5.95 U/mg (±0.9 with S.E.), respectively. Equilibrium reached after 180 min with production of 567.51 μM D-tagatose from 1000 mM of D-galactose. Though, the bioconversion ratio is low but it can be increased by immobilization and enzyme engineering. Although various L-arabinose isomerases have been characterized for bioproduction of D-tagatose, P. aeruginosa glucose phosphate isomerase is distinguished from the other L-arabinose isomerases by its optimal temperature (60 °C) for D-tagatose production being mesophilic bacteria, making it an alternate choice for bulk production.

Entities:  

Keywords:  D-Galactose; D-Tagatose; Phosphoglucose isomerase; Pseudomonas aeruginosa PAO1

Mesh:

Substances:

Year:  2016        PMID: 26922727     DOI: 10.1007/s12010-016-2026-7

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  1 in total

Review 1.  D-Tagatose Is a Promising Sweetener to Control Glycaemia: A New Functional Food.

Authors:  Marion Guerrero-Wyss; Samuel Durán Agüero; Lisse Angarita Dávila
Journal:  Biomed Res Int       Date:  2018-01-09       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.